title: [Cap polyposis and Helicobacter pylori].
authors.affiliation: Department of Internal Medicine III, Fukuoka University School of Medicine.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Nishiyama
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Maeda
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Aoyagi
authors.forename: Syotaro
authors.initials: S
authors.lastname: Sakisaka
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000368:Aged; D000658:Amoxicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001944:Breath Tests; D017291:Clarithromycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D016481:Helicobacter Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D044483:Intestinal Polyposis / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology; D064747:Lansoprazole; D009853:Omeprazole / Q000008:administration & dosage / Q000031:analogs & derivatives; D054328:Proton Pump Inhibitors; D016896:Treatment Outcome
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D000658:Amoxicillin; D017291:Clarithromycin; D009853:Omeprazole